1. Signaling Pathways
  2. Immunology/Inflammation
  3. Nectin-4
  4. Nectin-4 Inhibitor

Nectin-4 Inhibitor

Nectin-4 Inhibitors (3):

Cat. No. Product Name Effect Purity
  • HY-P99016
    Enfortumab
    Inhibitor 99.90%
    Enfortumab is a monoclonal antibody targeting Nectin-4. Enfortumab can used for researching urothelial cancer.
  • HY-P99016A
    Enfortumab vedotin-ejfv
    Inhibitor 99.28%
    Enfortumab vedotin-ejfv is an anti-Nectin-4 antibody-drug conjugate for the management of urothelial carcinoma.
  • HY-P99016B
    Enfortumab vedotin-ejfv (solution)
    Inhibitor 99.74%
    Enfortumab vedotin-ejfv (solution) is an anti-Nectin-4 antibody-drug conjugate for the management of urothelial carcinoma.